# US 2023/0405191 A1 · Antimicrobial catheters

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0405191 A1
- Document ID: US20230405191A1
- Status: Published application
- Kind: A1
- Application number: 18/456,061
- Filed: 2023-08-25
- Published: 2023-12-21
- Earliest claimed: 2013-04-18
- Assignees: Board of Regents, The University of Texas System
- Applicants: Board of Regents, The University of Texas System
- Inventors: Joel ROSENBLATT; Issam RAAD
- Web page: https://patentgrep.com/patent/US20230405191A1

## CPC

- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61K 31/14: Quaternary ammonium compounds, e.g. edrophonium, choline (betaines A61K31/205)
- A61K 31/155: Amidines ([IMAGE cpc-sch-A61K-1029.gif]), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A61K 31/165: having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K 31/496: Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A61K 31/65: Tetracyclines
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61L 29/041: {obtained by reactions only involving carbon-to-carbon unsaturated bonds}
- A61L 29/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 29/08: Materials for coatings
- A61L 29/085: {Macromolecular materials}
- A61P 31/04: Antibacterial agents
- A61L 2300/206: Biguanides, e.g. chlorohexidine
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L 2300/406: Antibiotics
- A61L 2300/442: Colorants, dyes
- A61L 2300/606: Coatings
- A61L 2420/02: Methods for coating medical devices
- A61L 2420/06: Coatings containing a mixture of two or more compounds
- A61L 2420/08: Coatings comprising two or more layers
- A61M 25/0009: {Making of catheters or other medical or surgical tubes}
- A61M 2025/0056: {provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir}
- A61M 2025/0057: {Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Antimicrobial catheters and medical devices are provided. In some aspects, a low durometer aliphatic polyether polyurethane may be impregnated with a first antimicrobial agent (e.g., minocycline and rifampin) and coated with a second antimicrobial agent (e.g., chlorhexidine, gendine, or gardine). The antimicrobial catheters may display improved flexibility and resistance to kinking. Methods of producing the antimicrobial catheters are also provided.

## Claims

### Claim 1

A medical device comprising an aliphatic polyether polyurethane polymer having a durometer of A or B wherein the polyurethane is impregnated with minocycline and rifampin.

### Claim 2 (depends on 1)

The medical device of claim 1, wherein the aliphatic polyether polyurethane polymer has a durometer of A.

### Claim 3 (depends on 1, 2)

The medical device of any one of claims 1-2, wherein the polyurethane is coated or impregnated with a guanidium compound.

### Claim 4 (depends on 3)

The medical device of claim 3, wherein the guanidium compound is chlorhexidine.

### Claim 5 (depends on 1, 2, 3, 4)

The medical device of any one of claims 1-4, wherein said coating further comprises a dye.

### Claim 6 (depends on 5)

The medical device of claim 5, wherein the dye is gendine or gardine.

### Claim 7 (depends on 1, 2, 3)

The medical device of any one of claims 1-3, wherein the polyurethane is coated with gendine, gardine, or chlorohexidine.

### Claim 8 (depends on 7)

The medical device of claim 7, wherein the polyurethane is coated with gendine, gardine, and chlorohexidine.

### Claim 9 (depends on 3)

The medical device of claim 3, wherein the guanidium compound is chlorhexidine.

### Claim 10 (depends on 1, 2, 3, 4)

The medical device of any one of claims 1-4, further comprises a dye impregnated into the polyurethane.

### Claim 11 (depends on 10)

The medical device of claim 10, wherein the dye is gendine or gardine.

### Claim 11 (depends on 17)

The medical device of claim 17, wherein m=1-50.

### Claim 12 (depends on 1, 2, 3)

The medical device of any one of claims 1-3, wherein the polyurethane is impregnated with gendine, gardine, or chlorohexidine.

### Claim 13 (depends on 12)

The medical device of claim 12, wherein the polyurethane is impregnated with gendine, gardine, and chlorohexidine.

### Claim 14 (depends on 3)

The medical device of claim 3, wherein the coating comprises a lower alcohol.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The medical device of any one of claims 1-14, wherein the polyurethane is impregnated with or coated with a fatty acid.

### Claim 16 (depends on 15)

The medical device of claim 15, wherein the fatty acid is caprylic acid (octanoic acid), caproic acid, lauric acid, or decanoic acid.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The medical device of any one of claims 1-16, wherein the aliphatic polyether polyurethane polymer has a repeating unit of the formula: [—O(CH2)n]m—OC(O)NH—(CH2)x—NHC(O)—; wherein n=1-4, x=1-12, m is 1-100; wherein the repeating unit repeats 1-250 times, and the terminus of the polymer is hydrogen.

### Claim 18 (depends on 17)

The medical device of claim 17, wherein x=1-10.

### Claim 19 (depends on 17)

The medical device of claim 17, wherein the polymer further comprises a polymer coating comprising chlorohexidine, gendine, or gardine.

### Claim 20 (depends on 19)

The medical device of claim 19, wherein the polymer coating further comprises a polyurethane, a silicone, a vinyl, a fluoropolymer, an olefin, or a polymer blend or copolymer thereof.

### Claim 21 (depends on 20)

The medical device of claim 20, wherein the polymer coating is a polyurethane coating.

### Claim 22 (depends on 21)

The medical device of claim 21, wherein the polyurethane coating is an aliphatic polyether polyurethane.

### Claim 23 (depends on 21)

The medical device of claim 21, wherein the polyurethane coating has a durometer of A or D, or the coating comprises a blend of A and D durometer aliphatic polyether polyurethanes.

### Claim 24 (depends on 19)

The medical device of claim 19, wherein the polyurethane coating comprises a blend of A and D durometer aliphatic polyether polyurethanes.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The medical device of any one of claims 1-24, wherein the aliphatic polyether polyurethane is comprised in a coating on the medical device.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The medical device of any one of claims 1-24, wherein the aliphatic polyether polyurethane is not comprised in a coating on the medical device.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The medical device of any one of claims 1-24, wherein the medical device does not comprise a penetrating or alkalizing agent.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The medical device of any one of claims 1-27, wherein the medical device is a catheter, an endotracheal tube, a nephrostomy tube, a biliary stent, an orthopedic device, a valve, a prosthetic valve, a drainage tube, a drain, a shunt, a staple, a clip, a mesh, a film, a blood exchanging device, a port, a cardiovascular device, a defibrillator, a pacemaker lead, a wire coating, an ocular implant, an auditory implant, a cochlear implant, a dental implant, a stimulator, a drug delivery depot, a filter, a membrane, a vascular access port, a stent, an envelope, a bag, a sleeve, intravenous or other tubing, a bag, a dressing, a patch, a fiber, a pin, a vascular graft, a suture, a cardiovascular suture, or an implantable prosthesis.

### Claim 29 (depends on 28)

The medical device of claim 28, wherein the medical device is a catheter.

### Claim 30 (depends on 29)

The medical device of claim 29, wherein the catheter is a vascular catheter, a urinary catheter, an intracranial catheter, an intraspinal catheter, a peritoneal catheter, a central nervous system catheter, a cardiovascular catheter, a drainage catheter, a soaker catheter, an aspirating catheter, an intrathecal catheter, a neural catheter, a stimulating catheter, or an epidural catheter.

### Claim 31 (depends on 30)

The medical device of claim 30, wherein the catheter is a vascular catheter.

### Claim 32 (depends on 31)

The medical device of claim 31, wherein the vascular catheter is a central venous catheter, an arterial line, an pulmonary artery catheter, a peripheral venous catheter, an intravenous catheter, or an intraarterial catheter.

### Claim 33 (depends on 1)

The medical device of claim 1, wherein a surface of the polyurethane is coated with gendine, gardine, or chlorohexidine in a lower alkyl alcohol solvent.

### Claim 34 (depends on 1)

The medical device of claim 1, wherein said minocycline and rifampin have been impregnated in the polyurethane using a solution that does not comprise a penetrating or alkalizing agent.

### Claim 35 (depends on 1)

The medical device of claim 1, wherein the medical device does not comprise a penetrating or alkalizing agent.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The medical device of any one of claims 1-35, wherein the polyurethane further comprises an additional therapeutic agent.

### Claim 37 (depends on 36)

The medical device of claim 36, wherein the additional therapeutic agent is impregnated in the polyurethane.

### Claim 38 (depends on 36)

The medical device of claim 36, wherein the additional therapeutic agent is coated on a surface of the polyurethane.

### Claim 39 (depends on 36)

The medical device of claim 36, wherein the therapeutic agent is an antimicrobial agent.

### Claim 40 (depends on 39)

The medical device of claim 39, wherein the antimicrobial agent is chlorhexidine, gendine, or gardine.

### Claim 41 (depends on 36)

The medical device of claim 36, wherein the additional therapeutic agent is a thrombin inhibitor, a platelet inhibitor, an anti-inflammatory agent, an anti-fibrotic agents, or a vasodilator.

### Claim 42 (depends on 41)

The medical device of claim 41, wherein the additional therapeutic agent is argatroban, dipyridamole, a glyceryl nitrate or mercaptoethane sulfonate (MeSNA).

### Claim 43 (depends on 36)

The medical device of claim 36, wherein the additional therapeutic agent is calcium channel blocker, or an anti-arrhythmia drug.

### Claim 44 (depends on 43)

The medical device of claim 43, wherein the additional therapeutic agent is verapamil or thioridazine.

### Claim 45 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The medical device of any one of claims 1-44, wherein the at least a portion of the medical device is coated with a hydrogel polyetherurethane.

### Claim 46 (depends on 45)

The medical device of claim 45, wherein the hydrogel polyetherurethane is a TECOPHILIC, TECOFLEX, or a polyurethane copolymer.

### Claim 47 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The medical device of any one of claims 1-46, wherein the medical device comprises polytetrafluoroethylene.

### Claim 48 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The medical device of any one of claims 1-46, wherein a surface of the medical device is coated or the device is impregnated with a chelator.

### Claim 49 (depends on 48)

The medical device of claim 48, wherein the chelator is calcium disodium EDTA.

### Claim 50 (depends on 49)

The medical device of claim 49, wherein the calcium disodium EDTA is comprised in an amount of about 0.01-1.5% EDTA in a coating solution.

### Claim 51 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The medical device of any one of claims 1-49, wherein the medical device is a catheter.

### Claim 52 (depends on 51)

The medical device of claim 51, wherein the catheter is a drainage catheter or a vascular catheter.

### Claim 53 (depends on 51)

The medical device of claim 51, wherein the catheter is impregnated or coated with chlorhexidine.

### Claim 54 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The medical device of any one of claims 1-53, wherein the aliphatic polyether polyurethane polymer is coated on the surface of the medical device.

### Claim 55

A medical device comprising an aliphatic polyether polyurethane polymer having a durometer of A or B wherein the polyurethane is impregnated with chlorhexidine, gendine, or gardine.

### Claim 56 (depends on 55)

The medical device of claim 55, wherein the aliphatic polyether polyurethane is coated with a second polymer.

### Claim 57 (depends on 56)

The medical device of claim 56, wherein the second polymer is a polyurethane.

### Claim 58 (depends on 55, 56, 57)

The medical device of any one of claims 55-57, wherein the aliphatic polyether polyurethane is impregnated with chlorhexidine and gardine.

### Claim 59 (depends on 55, 56, 57)

The medical device of any one of claims 55-57, wherein the aliphatic polyether polyurethane is impregnated with chlorhexidine and gendine.

### Claim 60 (depends on 55, 56, 57)

The medical device of any one of claims 55-57, wherein the aliphatic polyether polyurethane is impregnated with chlorhexidine, gendine, and gardine.

### Claim 61 (depends on 55, 56, 57, 58, 59, 60)

The medical device of any one of claims 55-60, wherein the second polymer comprises minocycline and rifampin.

### Claim 62 (depends on 61)

The medical device of claim 61, wherein the polymer is a polyurethane.

### Claim 63 (depends on 61)

The medical device of claim 61, wherein the polyurethane is an aliphatic polyether polyurethane.

### Claim 64 (depends on 55, 56, 57, 58, 59, 60, 61)

The medical device according to any one of claims 55-61, wherein the second polymer has a durometer of A or D, or the coating comprises a blend of A and D durometer aliphatic polyether polyurethanes.

### Claim 65 (depends on 55)

The medical device of claim 55, wherein the polyurethane coating comprises a blend of A and D durometer aliphatic polyether polyurethanes.

### Claim 66 (depends on 55)

The medical device of claim 55, wherein the medical device is a catheter.

### Claim 67 (depends on 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The medical device of any one of claims 55-66, wherein the at least a portion of the medical device is coated with a hydrogel polyetherurethane.

### Claim 68 (depends on 67)

The medical device of claim 67, wherein the hydrogel polyetherurethane is a TECOPHILIC, TECOFLEX, or a polyurethane copolymer.

### Claim 69 (depends on 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68)

The medical device of any one of claims 55-68, wherein a surface of the medical device is coated or impregnated with a chelator.

### Claim 70 (depends on 69)

The medical device of claim 69, wherein the chelator is calcium disodium EDTA.

### Claim 71 (depends on 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70)

The medical device of any one of claims 55-70, wherein the medical device is a catheter.

### Claim 72 (depends on 71)

The medical device of claim 71, wherein the catheter is a drainage catheter or a vascular catheter.

### Claim 73 (depends on 71)

The medical device of claim 71, wherein the catheter is impregnated or coated with chlorhexidine.

### Claim 74 (depends on 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)

The medical device of any one of claims 55-73, wherein the aliphatic polyether polyurethane polymer is coated on the surface of the medical device.

### Claim 75

A medical device, comprising a polymer impregnated with minocycline and rifampin, wherein a surface of the polymer is coated with a polymer coating comprising a fatty acid or a guanidium compound.

### Claim 76 (depends on 75)

The medical device of claim 75, wherein the polymer coating comprises a polyurethane, a silicone, a vinyl, a fluoropolymer, an olefin, or a polymer blend or copolymer thereof.

### Claim 77 (depends on 75)

The medical device of claim 75, wherein the polymer is polytetrafluoroethylene.

### Claim 78 (depends on 75)

The medical device of claim 75, wherein the polymer coating is a polyurethane coating.

### Claim 79 (depends on 78)

The medical device of claim 78, wherein the polyurethane coating has a durometer of A or D, or the coating comprises a blend of A and D durometer aliphatic polyether polyurethanes.

### Claim 80 (depends on 78)

The medical device of claim 78, wherein the polyurethane comprises chlorhexidine.

### Claim 81 (depends on 78)

The medical device of claim 78, wherein the fatty acid is caprylic acid (octanoic acid), caproic acid, lauric acid, or decanoic acid.

### Claim 82 (depends on 81)

The medical device of claim 81, wherein the fatty acid is capyrlic acid.

### Claim 83 (depends on 75, 76, 77, 78, 79, 80, 81, 82)

The medical device of claims 75-82, wherein the polymer coating further comprises mercaptoethane sulfonate (MeSNA).

### Claim 84 (depends on 83)

The medical device of claim 83, wherein the medical device further comprises a thrombin inhibitor, a platelet inhibitor, an anti-inflammatory agent, an anti-fibrotic agents, or a vasodilator.

### Claim 85 (depends on 75)

The medical device of claim 75, wherein the medical device further comprises a thrombin inhibitor, a platelet inhibitor, an anti-inflammatory agent, an anti-fibrotic agents, or a vasodilator.

### Claim 86 (depends on 75)

The medical device of claim 75, wherein the polymer is polyurethane, silicone, a polyvinyl chloride (PVC), a fluoropolymer, or a polyester, or a copolymer or blend thereof.

### Claim 87 (depends on 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86)

The medical device of any one of claims 75-86, wherein the at least a portion of the medical device is coated with a hydrogel polyetherurethane.

### Claim 88 (depends on 87)

The medical device of claim 87, wherein the hydrogel polyetherurethane is a TECOPHILIC, TECOFLEX, or a polyurethane copolymer.

### Claim 89 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88)

The medical device of any one of claims 1-88, wherein the medical device comprises polytetrafluoroethylene.

### Claim 90

The medical device of 40-50.3, wherein the polytetrafluoroethylene is TEFLON.

### Claim 91 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90)

The medical device of any one of claims 1-90, wherein a surface of the medical device is coated or impregnated with a chelator.

### Claim 92 (depends on 91)

The medical device of claim 91, wherein the chelator is calcium disodium EDTA.

### Claim 93 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92)

The medical device of any one of claims 1-92, wherein the medical device is a catheter.

### Claim 94 (depends on 93)

The medical device of claim 93, wherein the catheter is a drainage catheter or a vascular catheter.

### Claim 95 (depends on 93)

The medical device of claim 93, wherein the catheter is impregnated or coated with chlorhexidine.

### Claim 96 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96)

The medical device of any one of claims 1-96, wherein the aliphatic polyether polyurethane polymer is coated on the surface of the medical device.

### Claim 97

An antimicrobial catheter, wherein the body of the catheter comprises an A durometer aliphatic polyether polyurethane polymer, wherein the polyurethane is impregnated either with
(i) minocycline and rifampin; or
(ii) chlorhexidine, gendine, or gardine.

### Claim 98 (depends on 97)

The catheter of claim 97, wherein the aliphatic polyether polyurethane polymer has a repeating unit of the formula: [—O(CH2)n]m—OC(O)NH—(CH2)x—NHC(O)—; wherein n=1-4, x=1-10, m is less than 100, m is greater than x, the repeating unit repeats 1-250 times, and the terminus of the polymer is hydrogen.

### Claim 99 (depends on 98)

The catheter of claim 98, wherein the repeating unit repeats 1-100 times.

### Claim 100 (depends on 97, 98, 99)

The catheter of any one of claims 97-99, wherein the at least a portion of the medical device is coated with a hydrogel polyetherurethane.

### Claim 101 (depends on 99)

The catheter of claim 99, wherein the hydrogel polyetherurethane is a TECOPHILIC or a polyurethane copolymer.

### Claim 102 (depends on 97, 98, 99, 100, 101)

The catheter of any one of claims 97-101, wherein a surface of the medical device is coated or impregnated with a chelator.

### Claim 103 (depends on 102)

The catheter of claim 102, wherein the chelator is calcium disodium EDTA or a citrate.

### Claim 104 (depends on 97, 98, 99, 100, 101, 102, 103)

The catheter of claim 97-103, wherein the catheter is impregnated or coated with chlorhexidine.

### Claim 105 (depends on 97, 98, 99, 100, 101, 102, 103, 104)

The catheter of any one of claims 97-104, wherein the aliphatic polyether polyurethane polymer is coated on the surface of the medical device.

### Claim 106 (depends on 97, 98)

The catheter according to any one of claims 97-98, wherein the polyurethane further comprises a polyurethane coating comprising an additional therapeutic agent.

### Claim 107 (depends on 106)

The catheter of claim 106, wherein the additional therapeutic agent is an antimicrobial agent.

### Claim 108 (depends on 107)

The catheter of claim 107, wherein the antimicrobial agent is chlorhexidine, gendine, or gardine.

### Claim 109 (depends on 107)

The catheter of claim 107, wherein the coating comprises chlorhexidine and gendine.

### Claim 110 (depends on 107)

The catheter of claim 107, wherein the coating comprises chlorhexidine and gardine.

### Claim 111 (depends on 107)

The catheter of claim 107, wherein the antimicrobial agent is minocycline or rifampin.

### Claim 112 (depends on 107)

The catheter of claim 107, wherein the coating comprises minocycline and rifampin.

### Claim 113 (depends on 106)

The catheter of claim 106, wherein the additional therapeutic agent is a thrombin inhibitor, a platelet inhibitor, or a vasodilator.

### Claim 114 (depends on 113)

The catheter of claim 113, wherein the additional therapeutic agent is argatroban, dipyridamole, a glyceryl nitrate or a thrombin inhibitor.

### Claim 115 (depends on 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114)

The catheter according to any one of claims 97-114, wherein the catheter is a vascular catheter, a urinary catheter, an intracranial catheter, an intraspinal catheter, or an epidural catheter.

### Claim 116 (depends on 115)

The catheter of claim 115, wherein the catheter is a vascular catheter.

### Claim 117 (depends on 116)

The catheter of claim 116, wherein the vascular catheter is a central venous catheter, an arterial line, an pulmonary artery catheter, a peripheral venous catheter, an intravenous catheter, or an intraarterial catheter.

### Claim 118 (depends on 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117)

A method of catheterization comprising inserting a catheter of any one of claims 97-117 into a subject.

### Claim 119 (depends on 118)

The method of claim 118, wherein the subject is a mammal.

### Claim 120 (depends on 119)

The method of claim 119, wherein the subject is human.

### Claim 121

A method of producing an antimicrobial polymer, comprising:
(a) contacting an aliphatic polyether polyurethane with a solution comprising a first lower alcohol and at least one antimicrobial agent for an amount of time sufficient to impregnate the at least one antimicrobial agent in the aliphatic polyether polyurethane; wherein the solution does not contain a penetrating agent or an alkalizing agent; and
(b) substantially drying the aliphatic polyether polyurethane.

### Claim 122 (depends on 121)

The method of claim 121, wherein the at least one antimicrobial agent is minocycline and rifampin.

### Claim 123 (depends on 121)

The method of claim 121, wherein the at least one antimicrobial agent is chlorhexidine.

### Claim 124 (depends on 123)

The method of claim 123, wherein the at least one antimicrobial agent further comprises gendine or gardine.

### Claim 125 (depends on 121)

The method of claim 121, wherein the lower alcohol is a C1-6 alcohol.

### Claim 126 (depends on 125)

The method of claim 125, wherein the C1-6 alcohol is methanol, ethanol, propanol, butanol, or isopropanol.

### Claim 127 (depends on 126)

The method of claim 126, wherein the lower alcohol is methanol.

### Claim 128 (depends on 121)

The method of claim 121, wherein the solution consists of the lower alcohol.

### Claim 129 (depends on 121)

The method of claim 121, further comprising:
(c) subsequent to step (a), coating at least a portion of a surface of the aliphatic polyether polyurethane with a second solution comprising: a second lower alcohol, a second organic solvent, and an additional therapeutic compound.

### Claim 130 (depends on 129)

The method of claim 129, wherein said coating is applied to substantially all of the external surfaces of the aliphatic polyether polyurethane.

### Claim 131 (depends on 129)

The method of claim 129, wherein the second organic solvent is an aliphatic ether solvent or a chlorinated solvent.

### Claim 132 (depends on 131)

The method of claim 131, wherein the chlorinated solvent is methylene chloride or chloroform.

### Claim 133 (depends on 131)

The method of claim 131, wherein the aliphatic ether solvent is tetrahydrofuran or diethyl ether.

### Claim 134 (depends on 129)

The method of claim 129, wherein the second lower alcohol is the same alcohol as the first lower alcohol.

### Claim 135 (depends on 134)

The method of claim 134, wherein the second lower alcohol is a C1-6 alcohol.

### Claim 136 (depends on 135)

The method of claim 135, wherein the second lower alcohol is methanol, ethanol, propanol, butanol, or isopropanol.

### Claim 137 (depends on 136)

The method of claim 136, wherein the lower alcohol is methanol.

### Claim 138 (depends on 129)

The method of claim 129, wherein the solvent is tetrahydrofuran and the second lower alcohol is methanol.

### Claim 139 (depends on 129)

The method of claim 129, wherein the additional therapeutic compound is a second antimicrobial agent.

### Claim 140 (depends on 139)

The method of claim 139, wherein the second antimicrobial agent is chlorhexidine, gendine, gardine, minocycline, or rifampin.

### Claim 141 (depends on 129)

The method of claim 129, wherein the additional therapeutic agent is a thrombin inhibitor, a platelet inhibitor, an anti-inflammatory agent, an antifibrotic agent, or a vasodilator.

### Claim 142 (depends on 141)

The method of claim 141, wherein the additional therapeutic agent is argatroban, or dipyridamole.

### Claim 143 (depends on 129)

The method of claim 129, wherein the additional therapeutic agent is calcium channel blocker or an anti-arrhythmia drug.

### Claim 144 (depends on 143)

The method of claim 143, wherein the additional therapeutic agent is verapamil or thioridazine.

### Claim 145 (depends on 129)

The method of claim 129, wherein said coating has a durometer of A or D, or the coating comprises a blend of A and D durometer aliphatic polyether-urethanes.

### Claim 146 (depends on 121)

The method of claim 121, wherein the aliphatic polyether polyurethane has a repeating unit of the formula: [—O(CH2)n]m—OC(O)NH—(CH2)x—NHC(O)—; wherein n=1-4, x=1-10, m is less than 500, m is greater than x, the repeating unit repeats 1-250 times, and the terminus of the polymer is hydrogen.

### Claim 147 (depends on 146)

The method of claim 146, wherein m is 1-250.

### Claim 148 (depends on 146)

The method of claim 146, wherein the repeating unit repeats 1-100 times.

### Claim 149 (depends on 146)

The method of claim 146, wherein the resulting polyether polyurethane has a durometer of A or B.

### Claim 150 (depends on 121)

The method of claim 121, wherein the aliphatic polyether urethane polymer is comprised in a medical device or a catheter.

### Claim 151 (depends on 150)

The method of claim 150, wherein the aliphatic polyether urethane polymer is comprised in an endotracheal tube, a vascular catheter, a urinary catheter, a nephrostomy tube, a biliary stent, a peritoneal catheter, an epidural catheter, a central nervous system catheter, an intracranial catheter, an intraspinal catheter, an epidural catheter, an orthopedic device, a prosthetic valve, or a medical implant.

### Claim 152 (depends on 151)

The method of claim 151, wherein the catheter is a vascular catheter.

### Claim 153 (depends on 152)

The method of claim 152, wherein the vascular catheter is a central venous catheter, an arterial line, a pulmonary artery catheter, and a peripheral venous catheter, an intraarterial catheter, or intravenous (i.v.) tubing.

### Claim 154

A method of producing an antimicrobial polymer, comprising:
(a) contacting a polymer with a solution comprising a lower alcohol, minocycline, rifampin, and an alkalizing agent for an amount of time sufficient to impregnate the minocycline and rifampin in the aliphatic polyether polyurethane;
(b) exposing the polymer to a neutralizing solution comprising an alkanoic acid for an amount of time sufficient to substantially neutralize the alkalizing agent; and
(c) substantially drying the polymer.

### Claim 155 (depends on 154)

The method of claim 154, wherein the alkalizing agent is sodium hydroxide.

### Claim 156 (depends on 154)

The method of claim 154, wherein the solution further includes a penetrating agent.

### Claim 157 (depends on 156)

The method of claim 156, wherein the penetrating agent is ethyl acetate or butyl acetate.

### Claim 158 (depends on 154)

The method of claim 154, wherein the polymer is a polyurethane.

### Claim 159 (depends on 158)

The method of claim 158, wherein the polyurethane is an aliphatic polyether polyurethane.

### Claim 160 (depends on 154)

The method of claim 154, wherein step (b) comprises neutralizing a majority or substantially all of the alkylating agent.

### Claim 161 (depends on 154)

The method of claim 154, wherein the lower alcohol is methanol.

### Claim 162 (depends on 154)

The method of claim 154, wherein the alkanoic acid is a C1-6 alkanoic acid.

### Claim 163 (depends on 162)

The method of claim 162, wherein the C1-6 alkanoic acid is acetic acid, formic acid, propionic or butyric acid.

### Claim 164 (depends on 163)

The method of claim 163, wherein the C1-6 alkanoic acid is acetic acid.

### Claim 165 (depends on 154)

The method of claim 154, further comprising:
(d) subsequent to step (a), coating at least a portion of a surface of the aliphatic polyether polyurethane with a second solution comprising: a second lower alcohol, a second organic solvent, and an additional therapeutic compound.

### Claim 166 (depends on 165)

The method of claim 165, wherein said coating is applied to substantially all of the external surfaces of the aliphatic polyether polyurethane.

### Claim 167 (depends on 165)

The method of claim 165, wherein the second organic solvent is an aliphatic ether solvent or a chlorinated solvent.

### Claim 168 (depends on 167)

The method of claim 167, wherein the chlorinated solvent is methylene chloride or chloroform.

### Claim 169 (depends on 167)

The method of claim 167, wherein the aliphatic ether solvent is tetrahydrofuran or diethyl ether.

### Claim 170 (depends on 165)

The method of claim 165, wherein the second lower alcohol is the same alcohol as the first lower alcohol.

### Claim 171 (depends on 165)

The method of claim 165, wherein the second lower alcohol is methanol.

### Claim 172 (depends on 165)

The method of claim 165, wherein the solvent is tetrahydrofuran and the second lower alcohol is methanol.

### Claim 173 (depends on 165)

The method of claim 165, wherein the additional therapeutic compound is an antimicrobial agent.

### Claim 174 (depends on 173)

The method of claim 173, wherein the antimicrobial agent is chlorhexidine, gendine, or gardine.

### Claim 175 (depends on 165)

The method of claim 165, wherein the additional therapeutic agent is a thrombin inhibitor, a platelet inhibitor, an anti-inflammatory agent, an antifibrotic agent, or a vasodilator.

### Claim 176 (depends on 165)

The method of claim 165, wherein the additional therapeutic agent is argatroban, or dipyridamole.

### Claim 177 (depends on 165)

The method device of claim 165, wherein the additional therapeutic agent is calcium channel blocker or an anti-arrhythmia drug.

### Claim 178 (depends on 177)

The medical device of claim 177, wherein the additional therapeutic agent is verapamil or thioridazine.

### Claim 179 (depends on 165)

The method of claim 165, wherein said coating has a durometer of A or D, or the coating comprises a blend of A and D durometer aliphatic polyether-urethanes.

### Claim 180 (depends on 154)

The method of claim 154, wherein the aliphatic polyether urethane polymer is comprised in a medical device or a catheter.

### Claim 181 (depends on 154)

The method of claim 154, wherein the polymer is comprised in an endotracheal tube, a vascular catheter, a urinary catheter, a nephrostomy tube, a biliary stent, a peritoneal catheter, an epidural catheter, a central nervous system catheter, an intracranial catheter, an intraspinal catheter, an epidural catheter, an orthopedic device, a prosthetic valve, or a medical implant.

### Claim 182 (depends on 181)

The method of claim 181, wherein the catheter is a vascular catheter.

### Claim 183 (depends on 182)

The method of claim 182, wherein the vascular catheter is a central venous catheter, an arterial line, a pulmonary artery catheter, and a peripheral venous catheter, an intraarterial catheter, or intravenous (i.v.) tubing.

### Claim 184

A catheter comprising a polymer tubing, wherein the polymer tubing is an aliphatic polyether polyurethane polymer, a polyurethane polymer coated with an aliphatic polyether polyurethane polymer, or a polytetrafluoroethylene polymer coated with an aliphatic polyether polyurethane polymer; wherein the polymer is coated or impregnated with chlorhexidine, gendine, gardine, minocycline, and/or rifampin.

### Claim 185 (depends on 184)

The catheter of claim 184, further comprising a second polymer coating on the polymer tubing.

### Claim 186 (depends on 185)

The catheter of claim 185, wherein the second polymer coating comprises an aliphatic polyether polyurethane.

### Claim 187 (depends on 186)

The catheter of claim 186, wherein the coating comprises chlorhexidine, gendine, gardine, minocycline, and/or rifampin.

### Claim 188 (depends on 184, 185, 186, 187)

The catheter of any one of claims 184-187, wherein the device further comprises an additional therapeutic agent.
